Flurandrenolide Topical
22 interactions 133 cited referencesFlurandrenolide topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body and eczema (a skin disease that causes the skin to be dry and itchy and to so… Read the full Flurandrenolide Topical drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Flurandrenolide Topical Desmopressin DDAVP Increased risk of severe hyponatremia Details Flurandrenolide Topical Mifepristone Korlym An increased risk of autoimmune disorders and an increased risk of acute adrenal insufficiency, that may lead to exacerbation or d... DetailsMajor
Flurandrenolide Topical Aspirin Acuprin® An increased risk of salicylism subsequent to withdrawal of corticosteroids Details Flurandrenolide Topical Bemiparin Increased risk of bleeding Details Flurandrenolide Topical Carbamazepine Carbatrol Reduced corticosteroids exposure and reduced efficacy of corticosteroids Details Flurandrenolide Topical Cosyntropin False elevations of plasma cortisol levels Details Flurandrenolide Topical Ethinyl Estradiol Increased corticosteroid exposure Details Flurandrenolide Topical Fosphenytoin Cerebyx Reduced corticosteroid exposure Details Flurandrenolide Topical Insulin Aspart, Recombinant Fiasp Reduced blood glucose lowering effect of insulin Details Flurandrenolide Topical Lutetium Lu 177 Dotatate Decreased lutetium Lu 177 dotatate efficacy Details Flurandrenolide Topical Macimorelin False-positive or false-negative adult growth hormone deficiency diagnosis Details Flurandrenolide Topical Nadroparin Increased risk of bleeding Details Flurandrenolide Topical Phenytoin Dilantin Reduced corticosteroid exposure Details Flurandrenolide Topical Sargramostim Leukine Increased myeloproliferative effects of sargramostim Details Flurandrenolide Topical Somatrogon-Ghla Reduced serum cortisol exposure, an increased risk of central (secondary) hypoadrenalism and attenuated growth-promoting effects o... Details Flurandrenolide Topical Upadacitinib Rinvoq Increased risk of gastrointestinal perforations DetailsModerate
Flurandrenolide Topical Auranofin Ridaura Increased risk of auranofin-related adverse effects Details Flurandrenolide Topical Gallium Ga 68 Dotatate Increased risk of false negative imaging Details Flurandrenolide Topical Insulin Afrezza Reduced blood glucose lowering effect of insulin Details Flurandrenolide Topical Insulin Lispro, Recombinant Admelog May decrease blood glucose lowering effect of insulin lispro Details Flurandrenolide Topical Metformin Fortamet® An increased risk of hyperglycemia and potential loss of glycemic control Details Flurandrenolide Topical Testosterone Androderm Increased risk of edema DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist